Clinical Trial Services

>

Latest News

The innovative medical approach of immunotherapy, harnessing the body's immune system to fight diseases like cancer more effectively. Abstract concept. | Image Credit: © TensorSpark - © TensorSpark - stock.adobe.com
Nxera and Cancer Research UK Advance Oral EP4 Antagonist into Phase IIa Study

September 17th 2025

The Phase IIa trial will further explore the EP4 antagonist HTL0039732 in combination with immunotherapy to improve outcomes in resistant solid tumors and expand treatment options.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
CSL Backs Late-Stage Development of VarmX’s Coagulation Therapy VMX-C001X

September 16th 2025

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | Image Credit: © Tada Images - stock.adobe.com
FDA Halts Clinical Trials That Send US Patient Cells to Foreign Labs

June 20th 2025

In Modern Laboratory Senior Female Scientist Has Discussion with Young Male Laboratory Assistant. He Shows Her Data Charts on a Clipboard, She Analyzes it and Enters It into Her Computer. | Image Credit: © Gorodenkoff - stock.adobe.com
Taking Full Advantage of Service Providers

April 1st 2024

BillionPhotos.com - stock.adobe.com
Lilly to Acquire POINT Biopharma

October 5th 2023

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.